Somatic Mutation in Chronic Liver Disease
This study is investigating genetic changes, called somatic mutations, in liver cells affected by long-term liver disease. Chronic liver disease, caused by things like alcohol, fatty liver, and hepatitis, is a growing concern in the UK and increases the risk of liver cancer. Unfortunately, little is known about how healthy liver cells develop these genetic changes as disease progresses towards cancer. Researchers are studying tissue samples from adults with different types and stages of chronic liver disease to understand how various damaging factors lead to specific genetic changes. The aim is to identify new genetic targets that could lead to improved ways to diagnose, predict the course of, and treat chronic liver disease, ultimately improving patient outcomes.
At a glance
What is this study about?
In the UK and worldwide, more and more people are sadly dying from long-term liver diseases. The main causes include liver damage from alcohol, a condition called metabolic-dysfunction associated steatotic liver disease (MASLD – previously known as 'non-alcoholic fatty liver disease'), and viral infections like hepatitis. Having a chronic liver disease also significantly increases a person's risk of developing liver cancer, which is a serious condition with low survival rates.
At the moment, we don't fully understand how the cells in the liver gain tiny genetic changes, called 'somatic mutations,' as the liver goes from being healthy, to diseased, and then potentially to developing cancer. This study aims to look closely at these genetic changes in different types and stages of long-term liver disease. By doing this, researchers hope to learn how different things that harm the liver lead to particular genetic changes in its cells.
Understanding these specific changes related to different causes and stages of liver disease is very important. It could help scientists find new genetic targets. These targets could then guide future research towards developing improved ways to diagnose liver problems earlier, predict how a disease might progress, and create more effective treatments for chronic liver disease, ultimately improving life for patients.
Key takeaways
- Looks at genetic changes in liver cells linked to chronic liver disease.
- Aims to understand causes of liver cancer.
- Uses existing, stored liver tissue samples, no new patient involvement.
- Could help develop better ways to diagnose and treat liver conditions.
- Focuses on different types and stages of liver disease.
Who may be eligible?
This study uses existing liver tissue samples that have already been collected for research purposes.
To be included, the tissue samples must come from adults (aged 18 or over) who had liver biopsies, liver surgery, or liver transplants. Importantly, these patients must have given their consent (permission) for their tissue to be used for research, and all ethical approvals must be in place.
This means that no new patients are being asked to provide samples specifically for this study. The study will not use samples from children, samples other than liver tissue, or any samples where the original patient did not give their consent or where ethical approval is missing.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you an adult (18 years or older)?
- Did you have a liver biopsy, liver surgery, or liver transplant in the past?
- Did you give permission (consent) for your leftover tissue to be used for research?
- Was your tissue specifically from your liver?
What does participation involve?
If you are a patient, you will not be directly involved in providing new samples or undergoing any additional procedures for this study. This research uses liver tissue samples that have already been collected from adults in the past (for example, during a liver biopsy, liver surgery, or a liver transplant).
The samples used will be 'surplus' to what was needed for your original medical care, meaning they are left over after diagnosis or treatment. The researchers will then analyse the genetic makeup of these stored liver tissue samples. There are no study visits, new tests, medications, or follow-up appointments required from individual patients for this particular research.
Potential risks and benefits
Locations (1)
- Wellcome Sanger InstituteVerified postcodeCambridge, United Kingdom
Common questions
What is 'somatic mutation'?
Somatic mutations are tiny changes that happen in the genes of your body cells after you are born. They are not inherited from your parents and cannot be passed on to your children.
Will this study help me directly?
This study uses samples that have already been collected, so it won’t directly affect your current treatment. However, the findings could help doctors understand and treat liver disease better in the future.
What is 'chronic liver disease'?
Chronic liver disease means long-term damage or illness affecting your liver. It can be caused by many things, including alcohol, fatty liver, and certain viruses.
Is my privacy protected?
Yes, all samples are handled with strict privacy and ethical guidelines. Researchers will only use samples where proper consent and approvals are in place, and your personal information will be kept confidential.
Who is running this study?
This study is a collaboration between the University of Texas Southwestern and the Wellcome Sanger Institute, which are leading research organisations.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.